Sharma et al[17] studied, release of methyl CpG binding proteins and histone deacetylase 1 from the Estrogen receptor alpha promoter could take effect on reactivation in ER alpha-negative human breast cancer cells. This evidence concerns the gene ESR1 and breast carcinoma.